Wall Street's Favorite Stocks: Insulet a Buy, Chewy and Alarm.com to Avoid

Industry
โดย StockStory·Read original
Summary · why it matters

StockStory identifies Insulet as a stock where Wall Street's bullishness is justified, while recommending investors avoid Chewy and Alarm.com despite high consensus price targets. Insulet, maker of the Omnipod insulin delivery system, is favored for its steady constant currency growth, expanding free cash flow margin, and rising returns on capital. Chewy faces sluggish sales growth and low gross margins, while Alarm.com struggles with slowing demand and static operating margins. Insulet trades at 21.5 times forward earnings, Chewy at 7.9 times forward EV/EBITDA, and Alarm.com at 2.3 times forward price-to-sales.

Impact on stocks 4

Consumer Discretionary▼ · 2 stocks
Chewy Inc
CHWY
▼ NegativeDemandrelevance

Article cites sluggish sales growth for Chewy.

Artificial Intelligence▼ · 1 stocks
Biotech & Genomic Medicine▲ · 1 stocks
Insulet Corporation
PODD
▲ PositiveCapitalrelevance

Article highlights expanding free cash flow margin and rising returns on capital.

© 2026 MarketDXNews